Navigation Links
UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
Date:7/22/2009

oprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the value of its products in the market (including MuGard and the size of the overall market for mucositis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PA Game Commission: EHD Outbreak Update: Test Results Confirm EHD In Beaver County
2. UPDATE: Governor Rendell to Fight to Cover All Pennsylvanians During Statewide Bus Tour
3. Update: SpineMark Expands Management Team to Build Spine Care Network
4. Skin Cancer Prevention Update:
5. Update: Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador
6. VoIP-PAL.com, Inc. (Pink Sheets: VPLM.PK - News) UPDATE: Announces First Award Recipient of TalkfortheCure(TM) Dollars
7. UPDATE: Retirement Living TV Partners With Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare 08: Search for Solutions
8. UPDATE: Celebrating UC Success Announces Essay Contest Winners
9. UPDATE: Defense Health Board Traumatic Brain Injury Family Caregivers Panel
10. TCT update: press conference schedule announced for TCT
11. Economic Update: You Should Invest (in Your Appearance)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Today, Coastal Healthcare ... Clara County for the first time since ... Coastal Healthcare Administrators will be assuming responsibilities ... Physicians Foundation for Medical Care. ,, ... Coastal maintains close working relationships with all ...
(Date:12/15/2009)... often treated with hormones, but when the tumours start ... reveals a thesis from the Sahlgrenska Academy, at the ... for new treatments for hormone-resistant prostate cancer. , Late ... cancer has spread, most patients are given hormone therapy. ... and the tumour shrinks. , "The problem is that ...
(Date:12/15/2009)... new study published by The University of Western Ontario ... and unpaid work report higher average measures of happiness ... , The ,shared roles, category, where each partner,s unpaid ... unpaid work, is a growing category that now represents ... more likely to be in a shared roles model ...
(Date:12/15/2009)... Although seen as a potential heart disease therapy, raising ... a transfer protein may not be effective, a new ... Nutrition Research Center on Aging (USDA HNRCA) at Tufts ... an association between low plasma cholesterol ester transfer protein ... the Framingham Heart Study population. , CETP is a ...
(Date:12/15/2009)... about-face, the secretive Central Intelligence Agency has requested documents from ... them from the CIA itself under the Freedom of Information ... ... 15, 2009 -- In a bizarre about-face, the secretive Central ... though the writer had earlier obtained them from the CIA ...
Breaking Medicine News(10 mins):Health News:Coastal Healthcare Administrators Expands Provider Network to Santa Clara County 2Health News:More blood vessels in hormone-resistant prostate tumors 2Health News:Low cholesterol transfer protein activity associated with heart disease risk 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3
... building in the,surgical community and among industry sponsors ... February 18-23, 2008 in,Steamboat Springs, Colorado. The MISS ... in addition to its flagship sessions on,morbid obesity., ... MISS 2008 will expound,on the integrated, multidisciplinary team ...
... Jan. 25 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ... novel anti-infective products, today,announced that it has entered ... private placement of 8,750,000 shares of,its common stock ... warrants to purchase 3,500,000 shares of common stock ...
... Los Angeles, London, New Delhi, and Singapore (25 January, ... Analytic Therapy (CAT) is published in a third edition ... practical psychotherapy. , Building on the success and popularity ... (published by SAGE) illustrates in ordinary language how learned ...
... Center to Open Melrose, Massachusetts Location in ... ... New England announces the opening of a new office in Melrose, Mass. ... The,Melrose office, located at 830 Main Street, Suite 207, will begin,scheduling patients ...
... WASHINGTON, Jan. 24 U.S. Department of,Health ... recognized the first,set of interoperability standards developed ... http://www.hitsp.org ). The HITSP advanced three,of ... advancement of,interoperable health records and a Nationwide ...
... In observance of,National Children,s Dental Health Month ... sponsoring its annual poster,contest. All Pennsylvania third-grade students ... grand prize winner will receive a $1,000 education ... bookmarks to be distributed to all of,Pennsylvania,s public ...
Other Medicine News:Health News:Thought Leaders in Morbid Obesity Treatment Convene at Upcoming Surgical Conference 2Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 2Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 3Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 4Health News:Change for the better back with third edition 2Health News:Leading IVF Practice to Open 11th New England Location 2Health News:HHS Secretary Recognizes Products of HITSP Standards Work 2Health News:HHS Secretary Recognizes Products of HITSP Standards Work 3Health News:HHS Secretary Recognizes Products of HITSP Standards Work 4
(Date:12/15/2009)... Bend Research Inc. announced,today that its clients may now ... in technologies developed by the firm to enhance the ... Bend Research clients may now reference a Type ... with the FDA, Bend Research officials said. , ... and know it will assist our,clients in accelerating the ...
(Date:12/14/2009)... Research Group, Inc. released ChartTrends®: Biologics in ... insight into the management of RA patients. ... self-reported treatment approaches (as reported by 208 Rheumatologists) ... RA patients who are currently being treated with ... audit, patients had to currently be treated with ...
(Date:12/14/2009)... 14 Seven leading cancer ... US Oncology Research participated in ... the 2009 San Antonio Breast ... at the Henry B. Gonzalez ... Texas . Fifteen others presented ...
Breaking Medicine Technology:Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient 2New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 2New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 3US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9Repeat negative CT scan for lung cancer does not encourage ex smokers to resume the habit 10966 1Repeat negative CT scan for lung cancer does not encourage ex smokers to resume the habit 10966 2Reportlinker Adds Point of Care Diagnostics 62494 1Reportlinker Adds Point of Care Diagnostics 62494 2Reportlinker Adds Point of Care Diagnostics 62494 3Reportlinker Adds Point of Care Diagnostics 62494 4Reportlinker Adds Point of Care Diagnostics 62494 5Reportlinker Adds Point of Care Diagnostics 62494 6Reportlinker Adds Point of Care Diagnostics 62494 7Reportlinker Adds Point of Care Diagnostics 62494 8Reportlinker Adds Point of Care Diagnostics 62494 9Reportlinker Adds Point of Care Diagnostics 62494 10Reportlinker Adds Point of Care Diagnostics 62494 11Reportlinker Adds Point of Care Diagnostics 62494 12Natural Products Association Issues Statement on New Supplement Safety Campaign 62490 1Natural Products Association Issues Statement on New Supplement Safety Campaign 62490 2
... KENILWORTH, N.J., May 30 Schering-Plough,Corporation (NYSE: ... poster,discussions, and oral presentations from about 60 clinical ... presented at the upcoming 44th,Annual Meeting of the ... 30 - June 3. Data will be presented ...
... safety and tolerability, as well as ... -, ROCKVILLE, Md., May 30 Human Genome ... has initiated dosing in a Phase,1 clinical trial to ... HGS1029, as monotherapy in patients with advanced solid tumors., ...
Other Medicine Technology:About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO 2Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 2Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 3Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: